| Caveolin-1 Protein | |
|---|---|
| Protein Name | Caveolin-1 (CAV1) |
| Gene | [CAV1](/genes/caveolin-1) |
| UniProt | P49897 |
| Molecular Weight | ~22 kDa |
| Subcellular Localization | Plasma membrane (caveolae), Endoplasmic reticulum, Golgi |
| Protein Family | Caveolin family |
| Tissue Specificity | Endothelial cells, adipocytes, fibroblasts, [neurons](/entities/neurons) |
Caveolin-1 (CAV1) is a scaffolding protein that forms the structural basis of caveolae - flask-shaped invaginations of the plasma membrane involved in lipid raft organization, signal transduction, and cellular homeostasis[1]. Caveolin-1 plays critical roles in neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS) through its involvement in lipid metabolism, oxidative stress response, and neuroinflammation[2].
The CAV1 gene encodes caveolin-1, a 22-24 kDa integral membrane protein that serves as the principal structural component of caveolae. These microdomains are enriched in cholesterol, sphingolipids, and various signaling molecules, making them crucial hubs for cellular communication. In the brain, caveolin-1 is expressed in neurons, astrocytes, microglia, and endothelial cells of the blood-brain barrier[3].
Caveolin-1 possesses several distinctive structural features:
The protein forms homo-oligomers of ~14-16 monomers that assemble into the characteristic caveolae structure.
Caveolin-1 is essential for the formation and maintenance of caveolae:
Caveolin-1 regulates lipid homeostasis:
As a scaffolding protein, caveolin-1 modulates numerous signaling pathways:
In brain endothelial cells, caveolin-1 maintains:
Caveolin-1 plays complex roles in Alzheimer's disease pathogenesis:
In Parkinson's disease, caveolin-1 is implicated in:
Caveolin-1 involvement in ALS includes:
Caveolin-1 affects cerebrovascular function:
Caveolin-1 represents a therapeutic target for neurodegenerative diseases:
Caveolin-1 interacts with numerous proteins:
Caveolin-1 is expressed in:
The study of Caveolin 1 Protein (Cav1) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Rothberg et al. Caveolin: A Novel Integral Membrane Protein (1992). 1992. ↩︎
Ikezu et al. Caveolin in Neurodegeneration (2008). 2008. ↩︎
Shin et al. Caveolin-1 in Blood-Brain Barrier (2019). 2019. ↩︎
Bouzioukh et al. Caveolin-1 and Alzheimer's Disease (2021). 2021. ↩︎
Jiang et al. Caveolin-1 and Parkinson's Disease (2020). 2020. ↩︎